Surgical management and treatment of pancreatic fistulas (Q41139525)

27 September 2017

1 reference

title

Surgical management and treatment of pancreatic fistulas (English)

1 reference

27 September 2017

Ridgeway MG

1

1 reference

27 September 2017

Stabile BE

series ordinal

2

1 reference

27 September 2017

language of work or name

1 reference

1 October 1996

1 reference

Surgical Clinics of North America

27 September 2017

published in

1 reference

27 September 2017

volume

76

1 reference

27 September 2017

issue

5

1 reference

27 September 2017

page(s)

1159-1173

1 reference

Treatment of pancreatic fistula with the somatostatin analogue SMS 201-995.

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Somatostatin suppresses secretin and pancreatic exocrine secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Role of octreotide in the prevention of postoperative complications following pancreatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Octreotide therapy for pancreaticopleural fistula.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Standards for pancreatic resection in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Role of somatostatin and octreotide in the treatment of pancreatic pseudocyst, fistula and ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Are pancreatoenteric anastomoses improved by duct-to-mucosa sutures?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Gastrointestinal and Pancreatic Complications Associated With Severe Pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Pancreatic fistula cured by an endoprosthesis in the pancreatic duct

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Segmental occlusion of the pancreatic duct with prolamine to prevent fistula formation after distal pancreatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Stimulatory and Inhibitory Effects of Purified Hypothalamic Extracts on Growth Hormone Release from Rat Pituitaryin Vitro1

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Internal pancreatic fistula

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Prevention of pancreatic fistula by modified pancreaticojejunal anastomosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Somatostatin in the treatment of pancreatic ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Pancreatic ascites and effusion. Risk factors for failure of conservative therapy and the role of octreotide

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Treatment of pancreatic cutaneous fistulas with a somatostatin analog.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Somatostatin (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Endoscopic stent placement for internal and external pancreatic fistulas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Percutaneous pneumatic balloon dilation of the obstructed pancreaticojejunal anastomosis in the management of a case of intractable pancreatic cutaneous fistula

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Pancreaticogastrostomy after pancreatoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Treatment of pancreatic ascites and external pancreatic fistulas with a long-acting somatostatin analogue (Sandostatin).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Somatostatin in the management of gastrointestinal fistulas. A multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

Incidence and management of pancreatic and enteric fistulas after surgical management of severe necrotizing pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970504-1

7 January 2021

10.1016/S0039-6109(05)70504-1

Identifiers

DOI

1 reference

27 September 2017

1 reference